130 related articles for article (PubMed ID: 8032825)
21. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
[TBL] [Abstract][Full Text] [Related]
22. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
Sato T; Sakata Y; Tamura K
Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive substance in the sera of head and neck cancer patients.
Yamanaka N; Harabuchi Y; Himi T; Kataura A
Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271
[TBL] [Abstract][Full Text] [Related]
24. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
Horstmann M; Merseburger AS; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M
J Cancer Res Clin Oncol; 2005 Nov; 131(11):715-22. PubMed ID: 16080018
[TBL] [Abstract][Full Text] [Related]
25. Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma.
Winter H; Meimarakis G; Angele MK; Hummel M; Staehler M; Hoffmann RT; Hatz RA; Löhe F
J Urol; 2010 Nov; 184(5):1888-94. PubMed ID: 20846691
[TBL] [Abstract][Full Text] [Related]
26. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
Shibayama T; Nakazono M; Koyama Y; Deguchi N; Baba S; Jitsukawa S; Murai M; Tazaki H
Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
[TBL] [Abstract][Full Text] [Related]
27. Comparison of clinical and pathological characteristics in incidentally detected and suspected renal carcinoma.
Ueda T; Yasumasu T; Uozumi J; Naito S
Br J Urol; 1991 Nov; 68(5):470-2. PubMed ID: 1747720
[TBL] [Abstract][Full Text] [Related]
28. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
Miyata Y; Koga S; Nishikido M; Noguchi M; Kanda S; Hayashi T; Saito Y; Kanetake H
Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
[TBL] [Abstract][Full Text] [Related]
29. [Preoperative grading of renal cell carcinoma by plasma immunosuppressive acidic protein level and tumor diameter using discriminant analysis].
Igarashi T; Murakami S; Tanaka M; Isaka S; Okano T; Shimazaki J; Matsuzaki O
Nihon Hinyokika Gakkai Zasshi; 1993 May; 84(5):884-9. PubMed ID: 8320894
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of serum basic fetoprotein--comparative study of serum immunosuppressive acid protein].
Gohji K; Arakawa S; Matsumoto O; Kamidono S; Oshima H; Nagata H; Iwamoto T; Hirooka K; Shimatani N; Inoue T
Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):711-8. PubMed ID: 2474083
[TBL] [Abstract][Full Text] [Related]
31. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer.
Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Ohta Y; Watanabe G
Chest; 2004 Aug; 126(2):342-6. PubMed ID: 15302715
[TBL] [Abstract][Full Text] [Related]
32. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume.
Partin AW; Criley SR; Steiner MS; Hsieh K; Simons JW; Lumadue J; Carter HB; Marshall FF
Urology; 1995 Feb; 45(2):211-7. PubMed ID: 7855968
[TBL] [Abstract][Full Text] [Related]
33. Lymph node dissection is not obsolete in clinically node-negative renal cell carcinoma patients.
Van Poppel H
Eur Urol; 2011 Jan; 59(1):24-5. PubMed ID: 20943309
[No Abstract] [Full Text] [Related]
34. Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion.
de la Taille A; Cao Y; Sawczuk IS; Nozemu T; d'Agati V; McKiernan JM; Bagiella E; Buttyan R; Burchardt M; Olsson CA; Bander N; Katz AE
Cancer Detect Prev; 2000; 24(6):579-88. PubMed ID: 11198272
[TBL] [Abstract][Full Text] [Related]
35. [Study of PyNPase activity in patients with gastric cancer--the association with preoperative IAP values].
Kirita T; Hamano K; Mabuchi G; Seshimo A; Kawase A; Miyashita M; Inada N
Gan To Kagaku Ryoho; 1995 Mar; 22(4):509-14. PubMed ID: 7887642
[TBL] [Abstract][Full Text] [Related]
36. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma.
Dong D; Jia L; Zhou Y; Ren L; Li J; Zhang J
Urol Oncol; 2017 May; 35(5):279-285. PubMed ID: 28110976
[TBL] [Abstract][Full Text] [Related]
37. Extension of survival by resection of asynchronous renal cell carcinoma metastases to mediastinal lymph nodes.
Whitson BA; Groth SS; Andrade RS; Garrett L; Dudek AZ; Jessurun J; Maddaus MA
J Thorac Cardiovasc Surg; 2008 May; 135(5):1022-8. PubMed ID: 18455579
[TBL] [Abstract][Full Text] [Related]
38. Tumour-associated trypsin inhibitor and renal cell carcinoma.
Meria P; Toubert ME; Cussenot O; Bassi S; Janssen T; Desgrandchamps F; Cortesse A; Schlageter MH; Teillac P; Le Duc A
Eur Urol; 1995; 27(3):223-6. PubMed ID: 7601186
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma.
Grankvist K; Ljungberg B; Rasmuson T
Int J Cancer; 1997 Apr; 74(2):233-6. PubMed ID: 9133462
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.
Papworth K; Grankvist K; Ljungberg B; Rasmuson T
Tumour Biol; 2005; 26(4):201-6. PubMed ID: 16006777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
